|NanoCor Therapeutics, Inc.
Biotechnology company founded to create viable intracellular genetic protein therapy for the treatment of Chronic Heart Failure. NanoCor has obtained rights to the Biological NanoParticle (BNP®) technology platform. BNPs are derived from Adeno-Associated Viral vectors.
|Nature Technology Corporation
Bioengineering technology company, providing industry solutions for design, research, process development and manufacturing of biologics, including gene-therapeutics and vaccines.
Biotechnology company dedicated to the development of sight-saving therapeutics for chronic retinal diseases. Neurotech’s lead product (NT-501) is in clinical development for the treatment of retinal degeneration and geographic atrophy.
Novasep is a contract manufacturing organization specialized in the production of viruses & viral vectors for gene therapy. Novasep offers specific know-how for culture and purification using the latest single-use and reusable technologies. From process development to the fill & finish step, Novasep is committed to the success of its customers.